Alexi M.
About Alexi M.
Alexi M. is a Research Associate at the Broad Institute of MIT and Harvard, focusing on cancer research within the National Cancer Institute's CPTAC effort. With a background in biology from Columbia University and experience in venture capital, Alexi has developed a diverse skill set in both research and entrepreneurship.
Work at Broad Institute
Currently, Alexi M. serves as a Research Associate at the Broad Institute of MIT and Harvard, a position held since 2022. In this role, Alexi is involved in the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) effort, focusing on cancer research within the Broad Institute's Proteomics Platform. This work contributes to advancing understanding in cancer biology and the development of new therapeutic strategies.
Education and Expertise
Alexi M. earned a Bachelor of Arts in Biology from Columbia University, completing the program from 2018 to 2022. Prior to this, Alexi attended Phillips Exeter Academy, where a High School Diploma was obtained from 2014 to 2018. The educational background provides a strong foundation in biological sciences, complemented by hands-on research experience across various prestigious institutions.
Background in Research
Alexi M. has a diverse background in research, having completed multiple summer research positions. These include roles at Baylor College of Medicine, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, and Mass General Hospital. Each of these experiences contributed to a comprehensive understanding of biomedical research and laboratory techniques.
Venture Capital Experience
In addition to research roles, Alexi M. has experience in venture capital, specifically as a Junior Analyst at SpringTide Ventures in 2021. This role, which lasted for five months, expanded Alexi's ambitions and skills, providing insights into the intersection of finance and biotechnology.
Startup Co-founder
Alexi M. co-founded a biotech startup, which reflects an entrepreneurial spirit and a commitment to applying scientific knowledge in practical settings. This initiative demonstrates the ability to bridge laboratory research with business development in the biotechnology sector.